Skip to main content

Table 3 Comparison of laboratory indexes between the two groups at admission and 72 h after admission

From: A retrospective analysis of the clinical efficacy of pancreatic duct stent implantation in the management of acute biliary pancreatitis requiring ERCP

Variable

Pancreatic duct stent group (n = 141)

Non-pancreatic duct stent group (n = 88)

P

AMY[U/L,M (IQR)]

 On admission

1123.70 (717.00–17912.00)

865.75 (504.75–1316.85)

0.011

 72 h

145.70 (97.60–279.05)

107.30 (66.80–168.10)

0.001

 Difference

869.00 (506.45–1483.40)

680.70 (388.70–1163.00)

0.085

WBC[× 109/L,M (IQR)]

 On admission

11.40 (8.66–15.35)

10.97 (7.99–15.13)

0.465

 72 h

9.23 (6.09–11.93)

7.95 (5.59–10.89)

0.083

 Difference

1.88 (-0.88–5.86)

2.15 (-0.07–5.96)

0.462

ALT[U/L,M (IQR)]

 On admission

243.80 (118.50–423.90)

257.10 (150.65–426.50)

0.416

 72 h

97.00 (56.55–172.20)

110.00 (70.90–179.15)

0.220

 Difference

114.40 (52.55–248.25)

125.90 (51.55–252.40)

0.712

TBIL[umol/L,M (IQR)]

 On admission

68.70 (41.55–114.30)

86.10 (50.15–117.85)

0.117

 72 h

30.30 (18.00–46.20)

29.80 (19.50–55.60)

0.439

 Difference

37.60 (14.85–69.15)

41.50 (21.15–73.00)

0.216

HCT[%,M (IQR)]

 On admission

43.60 (39.35–47.45)

41.25 (37.83–44.10)

0.001

 72 h

38.90 (34.85–42.85)

38.40 (35.70–40.85)

0.422

 Difference

4.40 (1.75–7.40)

2.40 (0.80–5.20)

0.001

LIP[IU/L,M (IQR)]

 On admission

8582.50 (4292.50–14294.50)

5222.50 (709.50–9957.00)

0.012

 72 h

717.00 (413.00–1525.50)

609.00 (296.25–1174.00)

0.085

 Difference

7322.00 (3561.00–13507.00)

3011.00 (70.00–9036.00)

0.006

CR[umol/L,M (IQR)]

 On admission

65.80 (55.95–80.40)

68.00 (52.85–80.47)

0.862

 72 h

61.30 (50.60–73.35)

59.50 (50.77–74.52)

0.598

 Difference

3.50 (− 1.85–12.70)

5.15 (− 0.42–13.93)

0.206